3[1]CAMILLERI-BROET S,VANDERWERFF H,CALDWELL E,et al.Distinct alterations in mitochondrial mass and function characterize different models of apoptosis[J].Exp Cell Res,1998,239(2):277-292. 被引量：1
4[4]HARE W,WOLDE MUSSIE E,LAI R,et al.Efficacy and Safety of me martine,an NMDA-type open-charrel blocker;for reduction of retinal injury associated with Expefimertal glaucoma in rat and monkey[J].Surv Ophthalmol,2001,45 (Suppl):284-289. 被引量：1
5[6]KOSEKI N,ARAIE M,YAMAGAMI J,et al.Effects of oral brovincamine on visual field damage in patients with normal-tension glaucoma with low-normal intraocular pressure[J].J Glaucoma,1999,8 (2):117-123. 被引量：1
6[7]THE RELATIONSHIP BETWEEN CONTROL OF INTRAOCULAR PRESSURE AND VISUAL FIELD DETERIORATION.The AGIS Investigators[J].Am J Ophthalmol,2000,130 (4):429-440. 被引量：1
7[8]SCHWARTZ B,TAKAMOTO T,LAVIN P.Increase of retinal vessel width in ocular hypertensives with timolol therapy[J].Acta Ophthalmol Scan Suppl,1995,215:41-53. 被引量：1
8[9]SCHWARTZ B,TAKAMOTO T,LAVIN P.Decrease of optic disc cupping and pallor of ocular hypertensives with timolol therapy[J].Acta Ophthalmol Scan Suppl,1995,215:5-21. 被引量：1
9[10]BURKE J,SCHWARTZ M.Preclinical evaluation of brimonidine[J].Surv Ophthalmol,1996,41 (Suppl 1):9-18. 被引量：1
